Sort by 'listens'
Novel Cancer Immunotherapies with SELLAS Life Sciences
The second episode of CureTalks with Gary discusses new immunotherapies with Sellas Life Sciences. Talking to Gary Petersen is Dr Angelos M. Stergiou CEO and President of Sellas Life Sciences and Senior Advisor for Sellas, Dr. Nicholas J Sarlis. Sellas…
Latest Advances in Myeloma Treatment: ASCO and EHA 2018 Highlights
The treatment field of Multiple Myeloma continues to move forward as novel agents and treatment combinations expand. Whether you are standard risk patient or belong to high-risk group, treatment paradigms are getting better. We are talking to Dr. Mateos on…
Evolving Treatment Landscape of Psoriasis. More than Skin Deep.
Psoriasis is one of the most common skin ailments, affecting about 2 percent of the population, across gender, age or socioeconomic status. The impact of this autoimmune skin condition goes much deeper with raised cardiovascular risk, inflammatory arthritis and other…
Drug Repurposing for COVID-19 with CORONA Registry (COvid 19 Registry of Off-label & New Agents)
The global crisis due to COVID19 and the urgent need to identify effective therapeutics prompted Dr. David Fajgenbaum from the University of Pennsylvania and his research team to create a database that tracks every off-label and experimental drug being used…
Understanding mRNA Covid-19 Vaccines
Messenger RNA vaccines, also called mRNA vaccines, are some of the first COVID-19 vaccines authorized for use in the United States. mRNA vaccines are a new type of vaccine to protect against infectious diseases. They teach the cells of our…